RO 646198

Drug Profile

RO 646198

Alternative Names: Ipidant

Latest Information Update: 05 Dec 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Roche
  • Class Anxiolytics
  • Mechanism of Action Nociceptin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Anxiety disorders

Most Recent Events

  • 25 Jul 2006 No development reported - Preclinical for Anxiety disorders in Switzerland (unspecified route)
  • 16 Aug 2002 A preclinical study has been added to the Anxiety Disorders pharmacodynamics section
  • 23 Apr 2002 A preclinical study has been added to the Anxiety Disorders pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top